Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 99

1.

A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.

Meltzer EO, Berger WE.

Allergy Asthma Proc. 2018 Jan 6;39(1):14-26. doi: 10.2500/aap.2018.39.4103.

PMID:
29279056
2.

A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.

Meltzer EO, Berger WE.

Allergy Asthma Proc. 2017 Nov 6. doi: 10.2500/aap.2017.38.1403. [Epub ahead of print]

PMID:
29108533
3.

Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis.

Nayak AS, Berger WE, LaForce CF, Urdaneta ER, Patel MK, Franklin KB, Wu MM.

Allergy Asthma Proc. 2017 May 1;38(3):222-230. doi: 10.2500/aap.2017.38.4050.

PMID:
28441993
4.

Diagnosis and management of allergic conjunctivitis in pediatric patients.

Berger WE, Granet DB, Kabat AG.

Allergy Asthma Proc. 2017 Jan 1;38(1):16-27. doi: 10.2500/aap.2017.38.4003. Review.

PMID:
28052798
5.

Intranasal spray medications for maintenance therapy of allergic rhinitis.

Berger WE, Meltzer EO.

Am J Rhinol Allergy. 2015 Jul-Aug;29(4):273-82. doi: 10.2500/ajra.2015.29.4215. Epub 2015 Jun 29. Review.

PMID:
26132312
6.

Efficacy and safety of beclomethasone dipropionate nasal aerosol in children with perennial allergic rhinitis.

Berger WE, Jacobs RL, Amar NJ, Tantry SK, Li J, Small CJ.

Ann Allergy Asthma Immunol. 2015 Aug;115(2):130-6. doi: 10.1016/j.anai.2015.05.012. Epub 2015 Jun 24.

7.

Flunisolide hydrofluoroalkane with integrated spacer for treating asthma: an updated review.

Berger WE, Tashkin DP.

Allergy Asthma Proc. 2015 Mar-Apr;36(2):105-15. doi: 10.2500/aap.2015.36.3835. Epub 2015 Jan 29. Review.

PMID:
25635610
8.

Intranasal triamcinolone and growth velocity.

Skoner DP, Berger WE, Gawchik SM, Akbary A, Qiu C.

Pediatrics. 2015 Feb;135(2):e348-56. doi: 10.1542/peds.2014-1641.

9.

Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.

Berger WE, Gillen M, Eckerwall G, Uryniak T, Trudo FJ, Lampl KL.

Allergy Asthma Proc. 2014 Mar-Apr;35(2):134-40. doi: 10.2500/aap.2014.35.3746.

PMID:
24717790
10.

Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis.

Berger WE, Shah S, Lieberman P, Hadley J, Price D, Munzel U, Bhatia S.

J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):179-85. doi: 10.1016/j.jaip.2013.09.019. Epub 2014 Jan 1.

PMID:
24607046
11.

A patient preference and satisfaction study of ciclesonide nasal aerosol and mometasone furoate aqueous nasal spray in patients with perennial allergic rhinitis.

Berger WE, Prenner B, Turner R, Meltzer EO.

Allergy Asthma Proc. 2013 Nov-Dec;34(6):542-50. doi: 10.2500/aap.2013.34.3705.

PMID:
24169063
12.

MP29-02 for the treatment of seasonal allergic rhinitis: a review of clinical pharmacology, efficacy and safety.

Berger WE.

Expert Rev Clin Immunol. 2013 Sep;9(9):803-11. doi: 10.1586/1744666X.2013.828876. Review.

PMID:
24070043
13.

Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma.

Berger WE, Bensch GW, Weinstein SF, Skoner DP, Prenner BM, Shekar T, Nolte H, Teper AA.

Pediatr Pulmonol. 2014 May;49(5):441-50. doi: 10.1002/ppul.22850. Epub 2013 Sep 9.

PMID:
24019197
14.

Efficacy, safety, and optimal dose selection of beclomethasone dipropionate nasal aerosol for seasonal allergic rhinitis in adolescents and adults.

Raphael GD, Berger WE, Prenner BM, Finn AF Jr, Kelley L, Tantry SK.

Curr Med Res Opin. 2013 Oct;29(10):1329-40. doi: 10.1185/03007995.2013.821055. Epub 2013 Aug 6.

PMID:
23815103
15.

Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.

Meltzer EO, Bernstein DI, Prenner BM, Berger WE, Shekar T, Teper AA.

Am J Rhinol Allergy. 2013 Mar-Apr;27(2):102-8. doi: 10.2500/ajra.2013.27.3864.

PMID:
23562197
16.

Particle size and small airway effects of mometasone furoate delivered by dry powder inhaler.

Berger R, Berger WE.

Allergy Asthma Proc. 2013 Jan-Feb;34(1):52-8. doi: 10.2500/aap.2013.34.3648.

PMID:
23406936
17.

A 26-week tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis.

Berger WE, Mohar DE, LaForce C, Raphael G, Desai SY, Huang H, Hinkle J.

Am J Rhinol Allergy. 2012 Jul-Aug;26(4):302-7. doi: 10.2500/ajra.2012.26.3773.

PMID:
22801019
18.

Efficacy and tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis.

Mohar D, Berger WE, Laforce C, Raphael G, Desai SY, Huang H, Hinkle J.

Allergy Asthma Proc. 2012 Jan-Feb;33(1):19-26. doi: 10.2500/aap.2012.33.3522.

PMID:
22370530
19.

Mometasone furoate/formoterol in the treatment of persistent asthma.

Berger WE.

Expert Rev Respir Med. 2011 Dec;5(6):739-46. doi: 10.1586/ers.11.71. Review.

PMID:
22082160
20.

Abstracts from the North American Rhinology & Allergy Conference, February 3, 2011, Puerto Rico.

Carr WW, Bernstein DI, Hampel FC, Gow JA, Williams JI, Zuraw BL, Chipps BE, Miller TA, Berger WE, Carr WW, Tort MJ.

Am J Rhinol Allergy. 2011 Sep 1;25(5):369. doi: 10.2500/ajra.2011.11.3699.

PMID:
29021069

Supplemental Content

Loading ...
Support Center